{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:22:32Z","timestamp":1787934152227,"version":"build-2784847793"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jacig.2024.100312","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T01:08:30Z","timestamp":1722042510000},"page":"100312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Novel germline STAT3 gain-of-function mutation causes autoimmune diseases and severe growth failure"],"prefix":"10.1016","volume":"3","author":[{"given":"Koji","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6390-8863","authenticated-orcid":false,"given":"Minoru","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Funajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Serada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoharu","family":"Ohkawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamiko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisato","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyuki","family":"Miya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Kosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiya","family":"Fujieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Naka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2024.100312_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jacig.2024.100312_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0968-0004(00)01624-8","article-title":"STAT proteins and transcriptional responses to extracellular signals","volume":"25","author":"Horvath","year":"2000","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jacig.2024.100312_bib3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jacig.2024.100312_bib4","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.4049\/jimmunol.161.9.4652","article-title":"Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice","volume":"161","author":"Takeda","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jacig.2024.100312_bib5","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2024.100312_bib6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaci.2009.10.059","article-title":"Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome","volume":"125","author":"Woellner","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100312_bib7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacig.2024.100312_bib8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jacig.2024.100312_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jacig.2024.100312_bib10","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review","volume":"7","author":"Fabre","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2024.100312_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12865-021-00411-1","article-title":"Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation","volume":"22","author":"Wang","year":"2021","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jacig.2024.100312_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s10038-022-01025-0","article-title":"Six years\u2019 accomplishment of the Initiative on Rare and Undiagnosed Diseases: nationwide project in Japan to discover causes, mechanisms, and cures","volume":"67","author":"Takahashi","year":"2022","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jacig.2024.100312_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cga.12400","article-title":"Role of chimeric transcript formation in the pathogenesis of birth defects","volume":"61","author":"Yamada","year":"2021","journal-title":"Congenit Anom (Kyoto)"},{"key":"10.1016\/j.jacig.2024.100312_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"10.1016\/j.jacig.2024.100312_bib15","doi-asserted-by":"crossref","first-page":"13130","DOI":"10.1073\/pnas.95.22.13130","article-title":"Three distinct domains of SSI-1\/SOCS-1\/JAB protein are required for its suppression of interleukin 6 signaling","volume":"95","author":"Narazaki","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacig.2024.100312_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1297\/cpe.25.71","article-title":"Growth standard charts for Japanese children with mean and standard deviation (SD) values based on the year 2000 national survey","volume":"25","author":"Isojima","year":"2016","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.1016\/j.jacig.2024.100312_bib18","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00431-013-2065-9","article-title":"Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis","volume":"172","author":"Doi","year":"2013","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jacig.2024.100312_bib19","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00431-015-2638-x","article-title":"Erratum to: Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis","volume":"174","author":"Doi","year":"2015","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jacig.2024.100312_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1750-1172-8-161","article-title":"New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare((R)) cohort","volume":"8","author":"Taytard","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jacig.2024.100312_bib21","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100312_bib22","article-title":"STAT3 gain-of-function syndrome","volume":"10","author":"Vogel","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jacig.2024.100312_bib23","first-page":"499","article-title":"Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption","volume":"52","author":"Halleen","year":"2006","journal-title":"Clin Lab"},{"key":"10.1016\/j.jacig.2024.100312_bib24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","article-title":"Osteoimmunology and the effects of the immune system on bone","volume":"5","author":"Takayanagi","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jacig.2024.100312_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/25785826.2023.2220931","article-title":"Osteoclast differentiation in rheumatoid arthritis","volume":"47","author":"Yokota","year":"2024","journal-title":"Immunol Med"},{"key":"10.1016\/j.jacig.2024.100312_bib26","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ajpath.2011.12.022","article-title":"STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP\/IPF","volume":"180","author":"Pechkovsky","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacig.2024.100312_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12931-020-1319-0","article-title":"TGF-beta pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling","volume":"21","author":"Epstein Shochet","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.jacig.2024.100312_bib42","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","article-title":"Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease","volume":"112","author":"Nishimoto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jacig.2024.100312_bib28","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2018.11.065","article-title":"Efficacy of ruxolitinib therapy in a patient with severe enterocolitis associated with a STAT3 gain-of-function mutation","volume":"156","author":"Parlato","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacig.2024.100312_bib29","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100312_bib30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1164\/rccm.201906-1204LE","article-title":"Successful treatment of interstitial lung disease in STAT3 gain-of-function using JAK inhibitors","volume":"202","author":"Silva-Carmona","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacig.2024.100312_bib31","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s10875-020-00864-w","article-title":"Ruxolitinib controls lymphoproliferation and diabetes in a STAT3-GOF patient","volume":"40","author":"Wegehaupt","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100312_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108316","article-title":"Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity","volume":"210","author":"Jagle","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100312_bib33","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jaci.2019.11.042","article-title":"Erythropoiesis defect observed in STAT3 GOF patients with severe anemia","volume":"145","author":"Mauracher","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100312_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.celrep.2017.03.055","article-title":"An activating STAT3 mutation causes neonatal diabetes through premature induction of pancreatic differentiation","volume":"19","author":"Saarimaki-Vire","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jacig.2024.100312_bib35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10875-020-00914-3","article-title":"Life-saving, dose-adjusted, targeted therapy in a patient with a STAT3 gain-of-function mutation","volume":"41","author":"Sarfati","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100312_bib36","doi-asserted-by":"crossref","first-page":"20037","DOI":"10.18632\/oncotarget.5042","article-title":"A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation","volume":"6","author":"Wienke","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jacig.2024.100312_bib37","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1096\/fasebj.9.9.7601338","article-title":"Proline motifs in peptides and their biological processing","volume":"9","author":"Vanhoof","year":"1995","journal-title":"FASEB J"},{"key":"10.1016\/j.jacig.2024.100312_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-90-481-9069-0_12","article-title":"Transcription factor effector domains","volume":"52","author":"Frietze","year":"2011","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.jacig.2024.100312_bib39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jaip.2020.11.044","article-title":"The new \u201cwholly trinity\u201d in the diagnosis and management of inborn errors of immunity","volume":"9","author":"Abraham","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2024.100312_bib40","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jaip.2018.12.022","article-title":"Now is the time to use molecular gene testing for the diagnosis of primary immune deficiencies","volume":"7","author":"Heimall","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2024.100312_bib41","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jaip.2018.12.017","article-title":"Mechanism-based precision therapy for the treatment of primary immunodeficiency and primary immunodysregulatory diseases","volume":"7","author":"Leiding","year":"2019","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324001085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324001085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T17:49:18Z","timestamp":1731347358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829324001085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2772829324001085"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100312","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel germline STAT3 gain-of-function mutation causes autoimmune diseases and severe growth failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100312"}}